Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Fen/Phen Settlement Amendment May Require Additional Reserves

This article was originally published in The Pink Sheet Daily

Executive Summary

The number of Redux patients that opt into the "seventh amendment" to the diet drug litigation settlement will determine whether Wyeth has adequate legal reserves. The amendment creates a $1.275 bil. fund for fen/phen patients with less serious medical conditions.

You may also be interested in...



Wyeth Accepts Redux Settlement Amendment

Wyeth has agreed to an amendment to the Redux class action settlement that covers claimants with less serious medical conditions, the company said Jan. 10

Wyeth Accepts Redux Settlement Amendment

Wyeth has agreed to an amendment to the Redux class action settlement that covers claimants with less serious medical conditions, the company said Jan. 10

Wyeth To Make Decision On Redux Settlement Amendment Next Week

Wyeth will decide the week of Jan. 10 whether to accept an amendment to the Redux class action settlement that covers claimants with less serious medical conditions, CEO Robert Essner said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel